Miromatrix Medical Inc. Operating Cash Flow
Miromatrix Medical Inc. reported Operating Cash Flow of -$18.26 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-14
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$4.57M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$5.07M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$8.62M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$6.06M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$26.68M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$14.81M.
- Miromatrix Medical Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$8.04M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$9.64M derived: sum of 2 quarters · filed 2023-11-14 | -$18.26M 10-Q · filed 2023-11-14 | -$24.31M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.68M 10-Q · filed 2023-08-14 | -$19.74M derived: sum of 3 quarters · filed 2023-08-14 | -$26.58M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$8.62M 10-Q · filed 2023-05-11 | -$14.67M derived: sum of 2 quarters · filed 2023-05-11 | -$21.51M derived: sum of 3 quarters · filed 2023-11-14 | -$27.87M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$12.89M derived: sum of 2 quarters · filed 2023-11-14 | -$19.25M derived: sum of 3 quarters · filed 2023-11-14 | -$26.68M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$6.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$13.20M derived: sum of 2 quarters · filed 2023-11-14 | -$20.63M 10-Q · filed 2023-11-14 | -$27.23M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.79M 10-Q · filed 2023-08-14 | -$20.39M derived: sum of 3 quarters · filed 2023-08-14 | -$23.21M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$7.43M 10-Q · filed 2023-05-11 | -$14.03M derived: sum of 2 quarters · filed 2023-05-11 | -$16.85M derived: sum of 3 quarters · filed 2023-05-11 | -$20.06M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.42M derived: sum of 2 quarters · filed 2023-03-31 | -$12.63M derived: sum of 3 quarters · filed 2023-03-31 | -$14.81M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.03M derived: sum of 2 quarters · filed 2022-11-14 | -$8.21M 10-Q · filed 2022-11-14 | -$10.15M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$5.39M 10-Q · filed 2022-08-15 | -$7.33M derived: sum of 3 quarters · filed 2022-08-15 | -$9.37M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$2.18M 10-Q · filed 2022-05-16 | -$4.12M derived: sum of 2 quarters · filed 2022-05-16 | -$6.16M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$3.98M derived: sum of 2 quarters · filed 2022-03-30 | -$8.04M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$6.09M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$4.05M 10-Q · filed 2021-08-12 |